Anxiety Disorders: Types, Symptoms, Causes and Complete Treatment Guide
- Dr. Tobias Kohler
- Jul 28
- 8 min read
Anxiety disorders are the most common mental health condition in the United States — and in the world. According to the National Institute of Mental Health (NIMH), 19.1% of US adults — approximately 42.5 million people — experienced an anxiety disorder in the past year, with a lifetime prevalence of 31.1%. Globally, around 301 million people were living with an anxiety disorder as of 2019, according to the World Health Organization.
Despite being highly treatable, anxiety disorders are dramatically undertreated. Only about 1 in 4 people with an anxiety disorder receives any treatment — a treatment gap driven by stigma, lack of awareness, cost, and limited access to mental health care. Yet with the right combination of psychotherapy, medication, and lifestyle approaches, the majority of people with anxiety disorders experience significant improvement or full remission.
This complete guide covers all major anxiety disorder types, how to recognise their symptoms, what causes them, and the full range of evidence-based treatment options available — including both talking therapies and medications.
The National Institute of Mental Health provides comprehensive anxiety disorder information at: https://www.nimh.nih.gov/health/topics/anxiety-disorders
If you or someone you know is in crisis, call or text the 988 Suicide and Crisis Lifeline at 988.
What Are Anxiety Disorders?
Anxiety disorders are a group of mental health conditions characterised by persistent, excessive fear or worry that is disproportionate to the situation and interferes with daily life. They are distinct from normal, adaptive anxiety — the healthy response to real threats that prepares the body to respond.
Normal anxiety is time-limited and proportionate to the stressor. Anxiety disorders involve anxiety that is:
Persistent — lasting weeks, months, or years rather than resolving when the stressor passes
Disproportionate — out of proportion to the actual level of threat
Impairing — interfering significantly with work, relationships, or daily activities
Difficult to control — not easily managed through reassurance or willpower
Anxiety disorders are biological conditions involving altered brain circuitry — particularly the amygdala (fear centre), prefrontal cortex (executive control), and the hypothalamic-pituitary-adrenal (HPA) axis — not character weaknesses or personal failures.
The Major Anxiety Disorder Types
1. Generalised Anxiety Disorder (GAD)
GAD is characterised by persistent, excessive worry about a wide range of everyday matters — health, finances, work, family, world events — that the person finds very difficult to control. The worry is present on most days for at least 6 months.
Key symptoms: persistent worry across multiple domains, restlessness or feeling on edge, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance.
GAD affects approximately 3.1% of US adults in any given year — about 6.8 million people. Women are twice as likely as men to be affected. The average age of onset is 31 years, but GAD can develop at any age.
2. Social Anxiety Disorder (SAD)
Social anxiety disorder — formerly called social phobia — is intense fear of social situations where the person might be judged, embarrassed, or scrutinised by others. This goes far beyond ordinary shyness — it is a debilitating fear that leads to significant avoidance of social situations.
Key symptoms: intense fear before or during social situations, fear of acting in a way that will be humiliating, physical symptoms (blushing, sweating, trembling, nausea), avoidance of social encounters, distress that interferes significantly with daily life.
Social anxiety disorder affects approximately 15 million US adults (7.1% of the population). Alarmingly, the ADAA reports that 36% of people with social anxiety disorder experience symptoms for 10 or more years before seeking help.
3. Panic Disorder
Panic disorder is characterised by recurrent, unexpected panic attacks — sudden surges of intense fear that peak within minutes — accompanied by persistent concern about future attacks and/or significant changes in behaviour to avoid them.
A panic attack includes 4 or more of: racing or pounding heart, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, numbness, chills or hot flushes, feelings of unreality (derealisation), fear of losing control or "going crazy," fear of dying.
Panic disorder affects approximately 6 million US adults (2.7%). It is twice as common in women. The key feature distinguishing panic disorder from a single panic attack is the persistent worry about further attacks and the behavioural changes that follow.
4. Specific Phobias
Intense, irrational fear of a specific object or situation — such as spiders (arachnophobia), heights (acrophobia), flying, needles, blood, or enclosed spaces — that leads to avoidance. Specific phobias are the most common anxiety disorder overall, affecting approximately 19.2 million US adults.
5. Agoraphobia
Fear and avoidance of situations where escape might be difficult or help unavailable during a panic attack — such as crowds, public transport, open spaces, or being outside the home alone. Often develops as a complication of panic disorder.
6. Separation Anxiety Disorder
Fear of separation from attachment figures — typically parents in children but can persist into adulthood. Now recognised in DSM-5 as occurring in adults as well as children.
Symptoms Comparison Across Types
Anxiety Type | Core Fear | Avoidance Pattern | Physical Symptoms | Minimum Duration |
GAD | Worry about many life domains | Difficult to avoid — worry is internal | Muscle tension, fatigue, sleep disturbance | 6 months |
Social anxiety disorder | Negative evaluation by others | Social situations, performance | Blushing, sweating, trembling | 6 months |
Panic disorder | Future panic attacks | Triggers associated with past attacks | Racing heart, chest pain, dizziness | 1 month of concern after attack |
Specific phobia | Specific object/situation | The specific feared stimulus | Racing heart, nausea, dizziness | 6 months |
Agoraphobia | Escape impossible/help unavailable | Public places, transport, outdoors | Panic-like physical symptoms | 6 months |
What Causes Anxiety Disorders?
Anxiety disorders arise from a complex interaction of biological, psychological, and environmental factors — not a single cause:
Biological factors:
Genetics
anxiety disorders are moderately heritable (heritability estimates 30–40%); having a first-degree relative with an anxiety disorder significantly increases risk
Brain circuitry
hyperactive amygdala response to threat cues, reduced prefrontal cortex regulation of fear responses, altered serotonin, noradrenaline, GABA, and glutamate neurotransmitter systems
HPA axis dysregulation
chronic stress response system activation; elevated cortisol
Temperament
behavioural inhibition in childhood (a shy, fearful temperament) is a strong predictor of later anxiety disorders
Psychological factors:
History of trauma or adverse childhood experiences
Learned helplessness and negative cognitive patterns (catastrophising, overestimation of threat, underestimation of coping ability)
Anxiety sensitivity — fear of anxiety symptoms themselves, a major maintaining factor in panic disorder
Environmental factors:
Stressful or traumatic life events (job loss, relationship breakdown, bereavement, illness)
Chronic stress — financial, occupational, relationship
Substance use — alcohol, cannabis, stimulants, and caffeine can all trigger or worsen anxiety
Medical conditions — thyroid disorders, cardiac arrhythmias, hypoglycaemia, and others can mimic or trigger anxiety
Treatment of Anxiety Disorders
Anxiety disorders respond very well to treatment. The two evidence-based pillars are psychotherapy (particularly CBT) and medication — and the combination is often more effective than either alone.
Psychotherapy — Cognitive Behavioural Therapy (CBT)
CBT is the gold-standard psychological treatment for all anxiety disorders, with the strongest evidence base across all types. CBT works by:
Identifying and challenging distorted, anxiety-maintaining thoughts (cognitive restructuring)
Gradual, structured exposure to feared situations or stimuli (exposure therapy) — reducing avoidance that maintains anxiety
Building skills for managing anxiety symptoms
For specific phobias, exposure therapy alone (graduated exposure to the feared stimulus) is highly effective. For social anxiety disorder, CBT produces remission in approximately 50–60% of patients. For panic disorder, CBT specifically targeting panic cognitions and interoceptive exposure (exposure to physical sensations of anxiety) is highly effective.
Medication — First-Line Pharmacological Options:
SSRIs (Selective Serotonin Reuptake Inhibitors)
SSRIs are the first-line medication for most anxiety disorders. They work by increasing serotonin availability in synapses, which modulates the fear circuitry over 2–6 weeks of treatment. Evidence-based options include:
Sertraline (Zoloft) — broadly effective across GAD, social anxiety, panic disorder
Escitalopram (Lexapro) — particularly well tolerated; widely used for GAD
Paroxetine (Paxil) — FDA-approved for GAD, social anxiety disorder, panic disorder
Fluoxetine (Prozac) — broad spectrum; longer half-life
SNRIs (Serotonin-Noradrenaline Reuptake Inhibitors)
Venlafaxine (Effexor) and Duloxetine (Cymbalta) are FDA-approved for GAD and effective for other anxiety disorders. Often preferred when anxiety coexists with significant pain or depression.
Pregabalin
Pregabalin (alpha-2-delta calcium channel modulator) is licensed for GAD in Europe and the UK and widely used off-label in the USA. Particularly useful when GAD coexists with neuropathic pain or fibromyalgia, or when SSRIs are not tolerated. Onset of anxiolytic effect within approximately 1 week — faster than SSRIs.
Buspirone
Non-addictive anxiolytic for GAD — works via serotonin 5-HT1A partial agonism. Slower onset (2–4 weeks) but no dependency risk or sedation. Not effective for panic disorder or social anxiety.
Benzodiazepines (short-term use only)
Lorazepam, Clonazepam, Diazepam — fast-acting and highly effective for acute anxiety but not recommended for long-term use due to tolerance, dependency, cognitive impairment, and withdrawal syndrome. Appropriate for short-term crisis management while waiting for SSRIs to take effect.
Beta-blockers (situational use)
Propranolol — used off-label for performance anxiety (situational social anxiety) to block the physical symptoms of anxiety (racing heart, trembling, sweating) before specific events. Not for generalised anxiety.
Anxiety Medication Comparison
Medication | Class | Best For | Onset | Dependency Risk |
Sertraline | SSRI | GAD, SAD, Panic disorder | 2–6 weeks | None |
Escitalopram | SSRI | GAD, SAD | 2–6 weeks | None |
Venlafaxine | SNRI | GAD, SAD, Panic disorder | 2–4 weeks | None |
Pregabalin | Alpha-2-delta | GAD, comorbid pain | ~1 week | Low-Moderate |
Buspirone | 5-HT1A agonist | GAD only | 2–4 weeks | None |
Lorazepam | Benzodiazepine | Short-term acute anxiety | Minutes | High |
Propranolol | Beta-blocker | Situational / performance anxiety | 1–2 hours | None |
Anxiety and Sleep — The Bidirectional Link
Anxiety and sleep disorders are deeply interconnected — each worsens the other. Anxiety activates the HPA axis and sympathetic nervous system, preventing the physiological relaxation needed to fall and stay asleep. Poor sleep in turn increases amygdala reactivity, reduces prefrontal cortex regulatory capacity, and heightens anxiety the following day.
Treating anxiety often significantly improves sleep. Conversely, CBT-I (Cognitive Behavioural Therapy for Insomnia) reduces anxiety as well as improving sleep in patients with both conditions.
For our complete guide to sleep disorders and treatments: [Sleep Apnea: Symptoms, Causes and Treatment]
For our guide on Pregabalin for anxiety versus Gabapentin — including full clinical evidence: [Pregabalin vs Gabapentin for Anxiety]
For our complete guide to insomnia causes: [What Causes Insomnia? 10 Reasons You Cannot Sleep]
Additional guidance on GAD diagnosis, symptoms, and treatment is available from NIMH at: https://www.nimh.nih.gov/health/publications/generalized-anxiety-disorder-gad
The WHO provides global mental health context and treatment information at: https://www.who.int/news-room/fact-sheets/detail/mental-disorders
Frequently Asked Questions
What is the difference between anxiety and an anxiety disorder?
Normal anxiety is a healthy, time-limited response to real stress or danger — it motivates action and resolves when the situation passes. An anxiety disorder involves anxiety that is persistent, disproportionate to the situation, difficult to control, and significantly interferes with daily life. The key clinical distinction is functional impairment — anxiety that consistently prevents you from living, working, or maintaining relationships as you want to indicates a disorder warranting professional evaluation.
Can anxiety be cured completely?
Many people with anxiety disorders achieve full remission with appropriate treatment — particularly with CBT and/or medication. Studies show 50 to 60 percent of people with GAD achieve remission with combined treatment. Some people experience anxiety as a recurring condition requiring ongoing management. Even for those who do not achieve full remission, treatment substantially reduces symptoms and improves quality of life. "Cure" in the sense of never experiencing anxiety again is not a realistic goal — anxiety is part of normal human experience — but living without an anxiety disorder is achievable for the majority of people who receive effective treatment.
How long does it take for anxiety medications to work?
SSRIs and SNRIs typically take 2 to 6 weeks to produce significant anxiety reduction, with maximum benefit at 8 to 12 weeks. Pregabalin may produce anxiolytic effects within approximately one week. Buspirone takes 2 to 4 weeks. Benzodiazepines work within minutes to hours. It is important not to stop SSRIs prematurely due to perceived lack of effect — the therapeutic window must be reached before judging response.
Is it safe to take anxiety medication long-term?
SSRIs and SNRIs are safe for long-term use — they are not addictive and do not lose effectiveness over time. Most guidelines recommend continuing effective treatment for at least 12 months after remission, then considering gradual tapering with close monitoring. Pregabalin has moderate dependency potential with prolonged use and requires tapering on discontinuation. Benzodiazepines should not be used long-term due to tolerance and dependency. Buspirone has no dependency risk and can be used long-term safely.
Can lifestyle changes alone treat anxiety disorders?
Lifestyle changes — regular aerobic exercise, adequate sleep, limiting caffeine and alcohol, mindfulness practice — have meaningful evidence-based anxiolytic effects and are important components of comprehensive anxiety management. However, for established anxiety disorders, lifestyle changes alone are generally insufficient as primary treatment. They are most effective as adjuncts to CBT and/or medication. For mild subclinical anxiety that does not yet meet disorder criteria, lifestyle intervention alone may be sufficient.
Comments